SCHEMBL21451952

SCHEMBL21451952

NC1(c2cccc(Cl)c2F)CCCCC1=O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 3/20 0.47
GRIN2A Q12879 3/20 0.47
SLC6A4 P31645 2/20 0.47
GRIN2D O15399 2/20 0.47
GRIN3B O60391 2/20 0.47
GRIN2B Q13224 2/20 0.47
GRIN2C Q14957 2/20 0.47
GRIN3A Q8TCU5 2/20 0.47
OPRK1 P41145 1/20 0.47
LMNA P02545 1/20 0.47
OPRM1 P35372 1/20 0.47
CACNA1C Q13936 1/20 0.47
HDAC4 P56524 3/20 0.40
BACE1 P56817 1/20 0.39
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTT P42858 1/20 0.38
GAA P10253 1/20 0.38
PDE7A Q13946 1/20 0.38
PDE7B Q9NP56 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21452495 0.85 HDAC4 (0.50) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
SCHEMBL30207561 0.85 HDAC4 (0.50) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL12601750 0.84 GRIN1 (0.59) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL3390132 0.84 GRIN1 (0.59) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL12601748 0.84 GRIN1 (0.59) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL30089863 0.84 GRIN1 (0.59) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL30089862 0.84 GRIN1 (0.59) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL30714777 0.84 GRIN1 (0.59) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
Norketamine SCHEMBL1997948 0.83 GRIN1 (0.57) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B
SCHEMBL21452531 0.83 GRIN1 (0.57) GRIN1GRIN2ASLC6A4GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171487-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI JIANHE PHARMACEUTICAL & TECHNOLOGY CO. LTD. (CN) 2021-06-10 US disclosed
EP-3778579-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Jianhe Pharmaceutical & Technology Co. Ltd. (CN) 2021-02-17 EP disclosed
WO-2019192602-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海键合医药科技有限公司 2019-10-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171487-A1 AROMATIC COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF CYP4F11, PAH, COMT GRIN1 1281/4885GRIN2A 3368/4885SLC6A4 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.